The Interesting Turn BMP2 Bone Grafting Is Taking

Image may be NSFW.
Clik here to view.

All BMP-2 bone grafting products require an FDA PMA for commercialization in the United States. Three young companies are working their ways through that gauntlet. If successful, and I think one or more will be, then Medtronic’s Infuse, the market leader in advanced osteogenetic bone grafts will have its first direct BMP competitor.

The post The Interesting Turn BMP2 Bone Grafting Is Taking first appeared on Orthopedics This Week.